JOYN Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-442
Closed -$37K 439
2018
Q4
$37K Sell
442
-26
-6% -$2.44K 0.01% 438
2018
Q3
$51K Buy
468
+4
+0.9% +$439 0.01% 383
2018
Q2
$51K Sell
464
-184
-28% -$19.2K 0.01% 387
2018
Q1
$65K Buy
+648
New +$66.4K 0.01% 391

Other funds holding DGX

JOYN Advisors's DGX Position: Q1 2019 in Review

JOYN Advisors sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 442 shares — an estimated $37K sold.

JOYN Advisors first reported a position in DGX in Q1 2018 and held it in 4 quarters. The position peaked at $65K in Q1 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • JOYN Advisors reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 442 Quest Diagnostics shares in Q1 2019, an estimated $37K.
  • JOYN Advisors first reported a position in Quest Diagnostics in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Quest Diagnostics position peaked at $65K in Q1 2018.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.